Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool December 13, 2011 Brian Orelli	Dividend? Buyback? Here's How to Get Both. But will there be enough to replenish the pipeline?
The Motley Fool November 19, 2010 Brian Orelli	One Drug, Two Names, Two Wildly Different Prospects Amgen double speaks for increased sales.
The Motley Fool October 25, 2011 Brian Orelli	Anemic Growth in All the Right Places Amgen's anemia drugs decline, but that's not its future anyway.
The Motley Fool October 24, 2006 Brian Lawler	Amgen's Ho-Hum Quarter With all the money flowing into its coffers, the biotech has no excuse not to start paying a dividend.
The Motley Fool February 17, 2005	What's a Dividend? A dividend is a portion of a company's earnings that the firm pays out to its shareholders.
The Motley Fool June 30, 2011 Todd Wenning	10 Stocks That Pay You Back Don't forget to include buybacks.
The Motley Fool August 27, 2009 Dan Caplinger	This Could Be Better Than Earning Dividends With the market down, share buybacks don't look as dumb as they used to.
The Motley Fool April 29, 2011 Brian Orelli	Show Us the Money, Drugmakers Drugmakers have cash and they aren't afraid to use it -- on themselves.
The Motley Fool August 13, 2010 Ilan Moscovitz	Merck: Dividend Dynamo or Disaster? Just how safe is this dividend?
BusinessWeek May 15, 2006 Arlene Weintraub	Rebuilding Amgen's Bones Amgen's mass-market osteoporosis drug could help reassure antsy investors.
The Motley Fool December 16, 2008 Brian Orelli	Pfizer Keeps the Change For the first time in decades, investors won't get a dividend increase.
The Motley Fool June 27, 2008	What's a Dividend? Some companies repay your investment with cold, hard cash.
The Motley Fool January 25, 2008 Selena Maranjian	Optimizing Dividends Look for solid and growing yields -- especially when stock prices fall.
The Motley Fool June 2, 2010 Brian Orelli	Little Surprise. Big Stock Move. Investors like Amgen's early approval;shares are up 9% today, well ahead of the overall market.
The Motley Fool January 28, 2008 Brian Lawler	A Wing and a Prayer for Amgen Amgen announces data from its top pipeline drug candidate. Investors, take note.
The Motley Fool February 28, 2011 Brian Orelli	Pharma's Newest Acquisition Targets Share buybacks are in at big pharma companies. Does it mean that licensing deals are out?
The Motley Fool August 23, 2010 Jordan DiPietro	How Safe Are Eli Lilly's Dividends? Check out how Eli Lilly stacks up
The Motley Fool January 26, 2007 Selena Maranjian	What Dividends Tell You Dividends can tell you a lot about a company -- perhaps more than you think.
The Motley Fool October 26, 2010 Brian Orelli	Thank Goodness for Amgen's New Kids The old drugs are dragging down Amgen's growth.
The Motley Fool August 29, 2008 Brian Orelli	Can Health-Care Dividends Hold Up? As many health-care companies' share prices drop, their dividend yields have become strikingly attractive. The big question, though, is whether these dividends can hold up.
The Motley Fool February 9, 2010 Brian Orelli	Bone Up On This Potential Blockbuster Amgen's denosumab passes another test on its way to potential blockbuster status.
The Motley Fool March 23, 2011 Todd Wenning	Dividend Report Card: Pfizer Investors considering Pfizer as a dividend play should decide if the combination of 4% current yield and low- to mid-single-digit dividend growth potential is a better deal than other pharmaceutical shares are offering.
The Motley Fool May 11, 2004	Dividend Growth Packs a Punch Dividend investing isn't necessarily slow-paced and boring.
The Motley Fool February 29, 2008 Brian Orelli	2007 Pharma Roundup How did big pharma do in 2007? With the drug sector earnings season winding down, now seems like a good time to take a look at how they fared and, more importantly, where they're headed.
The Motley Fool February 2, 2011 Brian Orelli	Pfizer's Newest Acquisition Target The pharma giant decided to cut potential acquisitions from its revenue guidance and instead spend the money on share buybacks.
The Motley Fool November 23, 2009 Dan Caplinger	Are These Dividends Too Good to Be True? Lots of high-yielding stocks won't last. Look for history and earnings.
The Motley Fool April 21, 2011 Luke Timmerman	Amgen Passes Key Trial With "Son of Dmab" for Osteoporosis The medical and scientific world will be chirping today about an interesting new finding Amgen has made for treating osteoporosis.
The Motley Fool December 20, 2005	Dividend Yield Physics Why do dividend yields rise when stock prices fall? It's because of a little simple math.
The Motley Fool February 8, 2010 Selena Maranjian	Good News About the Worst Year It's over. Remember, the overall trend of the market is up. When stocks of good, healthy, and growing companies get beaten down, they're likely to regain their footing.
The Motley Fool June 15, 2006 Selena Maranjian	My Dividends Are Bigger Than Yours Your yield may be 2% when mine is a whopping 13%. Here's the secret.
The Motley Fool January 25, 2011 Brian Orelli	2 Keys to Amgen's Continued Success Prolia and Xgeva have to perform.
The Motley Fool December 16, 2003 Rick Aristotle Munarriz	Amgen's Cannibalistic Ways Amgen's prospects look good, and it is planning a large share buyback.
The Motley Fool May 3, 2006 Selena Maranjian	When Dividends Are Dicey A hefty dividend yield isn't always something investors can count on.
The Motley Fool October 29, 2007 Brian Lawler	Amgen Revisited Third-quarter financials fail to impress, but there was good news, too from the biotech leader.
The Motley Fool March 18, 2011 Anders Bylund	Say Hello to Cisco's Newborn Cisco's first-ever cash dividend will be born as a $0.06 payout, and it's tagged as a quarterly dividend.
The Motley Fool December 20, 2006 Selena Maranjian	Buy Tomorrow's Big Yields Today Before it's too late, snap up a future 20% yield. The key is finding companies that have the fiscal strength to raise their dividend year after year. And they're out there.
The Motley Fool April 6, 2009 Selena Maranjian	How You Can Enjoy a 25% Dividend Yield Pay attention to the dividend growth rates of your investments, because a rapidly growing dividend can give you a steep yield on cost in a number of years.
The Motley Fool November 28, 2011	A Brief History of Amgen's Returns Amgen shares declined 17% over the past decade. What has happened?
The Motley Fool October 24, 2008 Brian Orelli	Amgen's Back Shares of Amgen are up 40% from their lows in March. And for good reason.
The Motley Fool July 21, 2011 Todd Wenning	What Does IBM Do With Its Free Cash? Let's find out whether it's a good steward of your capital.
The Motley Fool January 24, 2008 Selena Maranjian	Which Dividends Can You Count On? Some dividends are safe; while others are at risk.
The Motley Fool August 18, 2010 Jordan DiPietro	How Long Will Merck's Dividend Last? Check out how Merck stacks up in this article.
The Motley Fool April 28, 2008 Brian Lawler	Amgen's Anemic Earnings Drug troubles and potential label changes continue to hurt Amgen's earnings.
The Motley Fool July 8, 2009 Brian Orelli	Amgen Closes In on a Home Run Amgen already had a ball flying high above the outfield in its osteoporosis treatment, denosumab, but yesterday's clinical trial results were the wind that could push it out of the park.
The Motley Fool January 5, 2012 Dan Caplinger	Expect These Aristocrats to Pay You More Soon If you want higher dividends, these Aristocrats are worth keeping an eye on.
The Motley Fool November 30, 2004 Selena Maranjian	Focus on Future Dividend Yields Dividends have their place in many, if not most, portfolios. But don't just look for companies that are paying hefty dividends today. Here are two reasons why.
The Motley Fool October 30, 2009 Dan Caplinger	Should You Dump These Dividend Stocks? After the market's big rally, many stocks have seen their dividend yields drop sharply. Do those falling yields mean that you should get out of these dividend stocks now before it's too late?
The Motley Fool June 11, 2010 Morgan Housel	5 Dividend Monsters to Buy After the Crash The good news is that the recent crash has turned some traditional dividend stocks into veritable cash cows. Here are five: AT&T... Verizon... Altria... Southern Company... Eli Lilly...
The Motley Fool August 30, 2010 Ilan Moscovitz	Pfizer: Dividend Dynamo or Disaster? The stability and growth of Pfizer's dividend will depend on its ability to continue to develop and grow its pipeline of drugs and successfully integrate Wyeth.
The Motley Fool October 7, 2004 Charly Travers	Amgen's Next Blockbuster An osteoporosis drug could give the company its next big winner. With a P/E back in the mid 20s, the company is valued such that Amgen shareholders should be rewarded in the future if products are successful.